Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 35, Issue 5, 2006, Pages 301-306

  Kurokawa, Hideo ^a,b   Zhang, Min ^b   Matsumoto, Shinobu ^b   Yamashita, Yoshihiro ^b   Tanaka, Toshiko ^b   Takamori, Koichi ^a   Igawa, Kaori ^a   Yoshida, Maho ^a   Fukuyama, Hiroshi ^b   Takahashi, Tetsu ^b   Sakoda, Sumio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

Deep invasive front; Histological grade of malignancy; Oral squamous cell carcinoma; Syndecan 1 expression

Indexed keywords

SYNDECAN 1;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CELL DIFFERENTIATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; FEMALE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROPORTIONAL HAZARDS MODELS; PROTEOGLYCANS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; SYNDECAN-1; SYNDECANS;

EID: 33645709062     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00412.x     Document Type: Article

References (41)

1. Nyman J Mercke C Lindstroem J. Prognostic factors for local control and survival of cancer of the oral tongue: a retrospective analysis of 230 cases in Western Sweden. Acta Oncol 1993 32 667 73.
2. Overholt SM Eicher SA Wolf P Weber RS. Prognostic factors affecting outcome in lower gingival carcinoma. Laryngoscope 1996 106 1335 9.
3. Kurokawa H Yamashita Y Murata T et al. Clinicopathological evaluation of prognostic factors of oral squamous cell carcinoma patients with stage I and II. J Kyushu Dent Soc 1998 52 399 404.
4. Kurokawa H Yamashita Y Takeda S Zhang M Fukuyama H Takahashi T. Risk factor for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck 2002 24 731 6.
5. Kurokawa H Yamashita Y Matsumoto S et al. Estimation of invasive front grading and correlation with effect of preoperative chemotherapy in oral squamous cell carcinoma. Asian J Oral Maxillofac Surg 2003 15 186 93.
6. Kurokawa H Zhang M Yamashita Y et al. Risk factor for postoperative local recurrence of tongue carcinoma. Asian J Oral Maxillofac Surg 2004 16 84 9.
7. Kurokawa H Zhang M Matsumoto S et al. The relationship of the histologic grade at the deep invasive front and the expression of ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med 2005 34 602 7.
8. Bundgaard T Bentzen SM Wildt J Sorensen FB Sogaard H Nielsen JE. Histopathologic, stereologic, epidemiologic, and clinical parameters in the prognostic evaluation of squamous cell carcinoma of the oral cavity. Head Neck 1996 18 142 52.
9. Kurokawa H Yamashita Y Takeda S et al. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma. Fukuoka Acta Med 1999 90 6 13.
10. Kurokawa H Yamashita Y Takeda S et al. Estimation of tumor necrosis factor and manganese superoxide dismutase in oral squamous cell carcinoma - available methods for predicting the prognosis and monitoring the treatment. Asian J Oral Maxillofac Surg 2000 12 141 8.
11. Bryne M Koppang HS Lilleng R Stene T Bang G Dabelsteen E. New malignancy grading is a better prognostic indicator than Broder's grading in oral squamous cell carcinoma. J Oral Pathol Med 1989 18 432 7.
12. Bryne M. Prognostic value of various molecular and cellular features in oral squamous cell carcinoma. J Oral Pathol Med 1991 20 413 20.
13. Bryne M Koppang HS Lilleng R Kjaerheim A. Malignancy grading of the deep invasive margines of oral squamous cell carcinomas has high prognostic value. J Pathol 1992 166 375 81.
14. Tumluri V Thomas GA Fraser IS. Analysis of Ki-67 antigen at the invasive tumor front of human oral squamous cell carcinoma. J Oral Pathol Med 2003 31 598 604.
15. Tulumuri V Thomas GA Fraser IS. The relationship of proliferating cell density at the invasive tumor front with prognostic and risk factors in human oral squamous cell carcinoma. J Oral Pathol Med 2004 33 204 8.
16. Ito M Izumi N Cheng J et al. Jaw bone remodeling at the invasive front of gingiva squamous cell carcinomas. J Oral Pathol Med 2003 32 10 7.
17. Bryne M Jenssen N Boysen M. Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch 1995 427 277 81.
18. Kurokawa H Zhang M Matsumoto S et al. The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med 2005 34 329 33.
19. Hayashi K Hayashi M Jalkanen M et al. Immunocytochemistry of cell surface heparan sulfate proteogrlycan in mouse tissue: a light and electron microscopic study. J Histochem Cytochem 1987 35 1079 88.
20. Inki P Stenbaeck F Talve L Jalkanen M. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation. Am J Pathol 1991 169 1333 40.
21. Sanderson RD Hinkes MT Bernfield M. Syndecan-1, a cell surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol 1992 66 314 23.
22. Inki P Joensun H Grenman R Klemi P Jalkanen M. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer 1994 70 319 23.
23. Inki P Stenbaek F Grenman S Jalkanen M. Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J Pathol 2000 29 308 13.
24. Soukka T Pohjola J Inki P Happonen RP. Reduction of syndecan-1 expression is associated with dysplastic oral epithelium. J Oral Pathol Med 2000 29 308 13.
25. Kurokawa H Matsumoto S Murata T et al. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. J Oral Pathol Med 2003 32 513 21.
26. Kaplan E Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958 53 457 81.
27. Kearsley JH Bryson G Battistutta D Collins RJ. Prognostic importance of cellular DNA content in head and neck squamous cell cancer. Int Cancer 1991 47 31 7.
28. Liebersbach BF Saunderson RD. Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem 1994 269 20013 9.
29. Mali M Andtfolk H Miettinen HM Jalkanen M. Suppression of tumor cell growth by syndecan-1 ectodomain. J Biol Chem 1994 269 27795 8.
30. Liu W Litwach ED Stanley MJ Langford JK Lander AD Sanderson RD. Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. J Biol Chem 1998 273 22825 32.
31. Ito Y Yoshida H Nakano K et al. Syndecan-1 expression in thyroid carcinoma: stromal expression followed by epithelial expression is significantly correlated with dedifferentiation. Histopathol 2003 43 1365 71.
32. Matsumoto A Ono M Fujimoto Y Gallo RL Bernfield M Kohgo Y. Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer 1997 74 482 91.
33. Kumar-Singh S Jacobs W Dhaene K. et al. Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome. J Pathol 1998 186 300 5.
34. Stanley MJ Stanley MW Sanderson RD Zera R. Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol 1999 112 377 83.
35. Toyoshima E Ohsaki Y Nishigaki Y et al. Expression of syndecan-1 is common in human lung cancers independent of expression of epidermal growth factor receptor. Lung Cancer 2001 31 193 202.
36. Fujiya M Watari J Ashida T et al. Reduced expression of syndecan-1 affects metastatic potential outcome in patients with colorectal cancer. Jpn J Cancer Res 2001 92 1074 81.
37. Wiksten JP Lundin J Nordling S et al. Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer 2001 95 1 6.
38. Natarajan E Saeb M Crum CP Woo SB McKee PH Rheinwald JG. Co-expression of p16INK4A and laminin 5 γ2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound senscent keratinocytes in culture. Am J Pathol 2003 163 477 91.
39. Garner IB Smoller BR. The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamus cell carcinoma. J Cutan Pathol 2001 28 83 9.
40. Attonen A Kajanti M Heikkila P Jalkanen M Joensuu H. Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer 1999 79 558 64.
41. Mukunyadzi P Liu K Hanna EY Suen JY Fan CY. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Mod Pathol 2003 16 796 801.